Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
Cell-based immunotherapies, including CAR-T, CAR-NK, and TCR-T therapies, represent a transformative approach to cancer treatment by offering precise targeting of tumor cells.Despite their success in hematologic malignancies, these therapies encounter significant challenges in treating footjoy weste herren solid tumors, such as antigen heterogeneit